uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Austedo
Authorised
Human
Details
EMA number
EMEA/H/C/006371
ATC code
N07XX16
Authorisation
8 January 2026
Revision
-
EMA page
Therapeutic indication
Treatment of moderate to severe tardive dyskinesia in adults.
MeSH:
Tardive Dyskinesia
Group:
Other nervous system drugs
Special characteristics
Additional monitoring
Active substances
deutetrabenazine
Marketing Authorisation Holder
Teva GmbH
MAH
Timeline
Filter by authority:
EMA
Austedo authorised
8 Jan 2026
authorised
regulatory
Austedo | uMedical